Patents by Inventor Glenn B. Collins

Glenn B. Collins has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of bacterial acetate kinase and their genes for protection of plants against different pathogens
    Patent number: 6476293
    Abstract: An isolated gene fragment that encodes for acetate kinase, which confers disease resistance in plants is disclosed. The gene can be cloned into an expression vector to produce a recombinant DNA expression system suitable for insertion into cells to form a transgenic plant transformed with the gene fragment. A method for conferring disease resistance in plants that consists of growing plant host cells transformed with the expression system and expressing the gene conferring disease resistance to impart such resistance to host cells is also disclosed.
    Type: Grant
    Filed: October 1, 1999
    Date of Patent: November 5, 2002
    Assignee: University of Kentucky Research Foundation
    Inventors: Arthur G. Hunt, Glenn B. Collins, Christopher Lawrence, Qingshun Li, Santanu Dasgupta
  • Transgenic plants expressing MinD or MinE and an efficient method for plant chloroplast transformation and gene expression
    Publication number: 20020144309
    Abstract: The present invention concerns transgenic plant which contain large chloroplasts. The transgenic plant of the present invention comprises within its genome a foreign MinD or MinE gene or a foreign gene which expresses a protein which has the same functional activity as the Arabidopsis thaliana MinD or MinE protein. The present invention further concerns a method of producing the transgenic plants of the present invention which contain large chloroplasts. Finally, the present invention concerns a method of transforming the chloroplasts genome of the transgenic plants of the present invention which contain large chloroplasts.
    Type: Application
    Filed: February 8, 2002
    Publication date: October 3, 2002
    Inventors: Randy Dinkins, M.S. Srinivasa Reddy, Glenn B. Collins
  • KYRT1, a disarmed version of a highly tumorigenic Agrobacterium tumefaciens strain identified as Chry5
    Patent number: 5929306
    Abstract: Disarmed A. tumefaciencs strain KYRT1, derived from a highly tumorigenic strain identified as A. tumefaciens strain Chry5. Disarming is accomplished by inactivation of plasmid pTiChry5 T-DNA sequences by, for example, deletion of sequences comprising the T-DNA right border. Methods of making transgenic plants using the novel A. tumefaciens strains are also provided.
    Type: Grant
    Filed: November 15, 1996
    Date of Patent: July 27, 1999
    Assignee: University of Kentucky Research Foundation
    Inventors: Rebecca S. Torisky, Glenn B. Collins
  • Transformation, somatic embryogenesis and whole plant regeneration method for Glycine species
    Patent number: 5024944
    Abstract: A method for somatic embryogenesis of soybean, (Glycine max), Glycine soja and other Glycine species is provided using immature cotyledon tissue, preferably with the embryonic axis removed, comprising culturing said tissue on a medium containing auxin, preferably NAA at a concentration of at least about 15 mg/l. A further method for such somatic embryogenesis is provided wherein the culture medium contains a synergistically acting lowered carbohydrate and auxin concentration. Particularly embryogenic cells of such tissue are identified and improved maceration methods for contacting such cells with regeneration and transformation media are disclosed.Methods for transforming somatic tissue from soybean and other Glycine species are also provided.Whole, fertile, transformed plants are obtained.
    Type: Grant
    Filed: June 15, 1987
    Date of Patent: June 18, 1991
    Assignees: Lubrizol Genetics, Inc., The University of Kentucky Research Foundation, Inc.
    Inventors: Glenn B. Collins, David F. Hildebrand, Paul A. Lazzeri, Thomas R. Adams, Wayne A. Parrott, Lynn M. Hartweck